Efficacy and Safety of Erythropoietin to Prevent Acute Kidney Injury in Patients with Critical Illness or Perioperative Care: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Journal of Cardiovascular Pharmacology

Volumn 65, Issue 6, 2015, Pages 593-600

  Zhao, Chen ^a   Lin, Zhenchuan ^a   Luo, Qimei ^a   Xia, Xi ^a   Yu, Xueqing ^a   Huang, Fengxian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

acute kidney injury; critical illness; erythropoietin; meta analysis; perioperative care

Indexed keywords

ERYTHROPOIETIN; PLACEBO;

ACUTE KIDNEY FAILURE; ADVERSE DRUG REACTION; ARTICLE; CLINICAL EFFECTIVENESS; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIALYSIS; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT SAFETY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SYSTEMATIC REVIEW; ACUTE KIDNEY INJURY; ADULT; AGED; FEMALE; HEMODIALYSIS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; ADULT; AGED; CRITICAL ILLNESS; ERYTHROPOIETIN; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84934928382     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000229     Document Type: Article

References (28)

1. Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med. 2008;36:S146-S151.
2. Herrera-Gutiérrez ME, Seller-Pérez G, Sánchez-Izquierdo-Riera JA, et al. Prevalence of acute kidney injury in intensive care units: the "COrte de prevalencia de disFunción RenAl y DEpuración en críticos" point-prevalence multicenter study. J Crit Care. 2013;28:687-694.
3. Coca SG, Yusuf B, Shlipak MG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53:961-973.
4. Liotta M, Olsson D, Sartipy U, et al. Minimal changes in postoperative creatinine values and early and late mortality and cardiovascular events after coronary artery bypass grafting. Am J Cardiol. 2014;113:70-75.
5. Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10:193-207.
6. Jelkmann W. Erythropoietin after a century of research: younger than ever. Eur J Haematol. 2007;78:183-205.
7. Bernhardt WM, Eckardt KU. Physiological basis for the use of erythropoietin in critically ill patients at risk for acute kidney injury. Curr Opin Crit Care. 2008;14:621-626.
8. Coldewey SM, Khan AI, Kapoor A, et al. Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the b-common receptor. Kidney Int. 2013;84:482-490.
9. Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA. 2002;288:2827-2835.
10. Napolitano LM, Fabian TC, Kelly KM, et al. Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. J Trauma. 2008;65:285-297.
11. Endre ZH, Walker RJ, Pickering JW, et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int. 2010;77:1020-1030.
12. Yoo YC, Shim JK, Kim JC, et al. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011;115:929-937.
13. Oh SW, Chin HJ, Chae DW, et al. Erythropoietin improves long-term outcomes in patients with acute kidney injury after coronary artery bypass grafting. J Korean Med Sci. 2012;27:506-511.
14. de Seigneux S, Ponte B, Weiss L, et al. Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study. BMC Nephrol. 2012;13:132.
15. Tasanarong A, Duangchana S, Sumransurp S, et al. Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and Neutrophil Gelatinase-associated Lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trial. BMC Nephrol. 2013;14:136.
16. Kim JH, Shim JK, Song JW, et al. Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety. Crit Care. 2013;17:R254.
17. Kim JE, Ham SY, Shim YH. Prevention of acute kidney injury by erythropoietin in patients undergoing thoracic aorta surgery with hypothermic circulatory arrest. Eur J Anaesthesiol. 2013;30(suppl 51):63-64.
18. Dardashti A, Ederoth P, Algotsson L, et al. Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial). Anesthesiology. 2014;121:582-590.
19. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
20. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions Version 5.1.0 (updated March 2011). Available at: http://handbook.cochrane.org. Accessed October 1, 2014.
21. Song YR, Lee T, You SJ, et al. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol. 2009;30:253-260.
22. Clec'h C, Gonzalez F, Lautrette A, et al. Multiple-center evaluation of mortality associated with acute kidney injury in critically ill patients: a competing risks analysis. Crit Care. 2011;15:R128.
23. Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int. 2012;81:819-825.
24. Wang G, Huang H, Wu H, et al. Erythropoietin attenuates cardiopulmonary bypass-induced renal inflammatory injury by inhibiting nuclear factor-κB p65 expression. Eur J Pharmacol. 2012;689:154-159.
25. Stoyanoff TR, Todaro JS, Aguirre MV, et al. Amelioration of lipopolysaccharide-induced acute kidney injury by erythropoietin: involvement of mitochondria-regulated apoptosis. Toxicology. 2014;318:13-21.
26. Ghaboura N, Tamareille S, Ducluzeau PH, et al. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemicreperfusion injury by alteration of the RISK/GSK-3β signaling. Basic Res Cardiol. 2011;106:147-162.
27. Matějková Š, Scheuerle A, Wagner F, et al. Carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine kidney ischemia/reperfusion injury. Intensive Care Med. 2013;39:497-510.
28. Zacharias M, Mugawar M, Herbison GP, et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev. 2013;9:CD003590.